Skip to main content

Latest stock market podcasts

Part 2 Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 27 August

Jessica Amir
August 27, 2021

Morning Bell 27 August

Sophia Mavridis
August 27, 2021

Morning Bell 26 August

Paulina Peters
August 26, 2021

Morning Bell 25 August

Jessica Amir
August 25, 2021

Morning Bell 24 August

Jessica Amir
August 24, 2021

Morning Bell 23 August

Jessica Amir
August 23, 2021

Weekly Wrap 20 August

Jessica Amir
August 20, 2021

Morning Bell 20 August

Sophia Mavridis
August 20, 2021

Morning Bell 19 August

Paulina Peters
August 19, 2021

Morning Bell 18 August

Jessica Amir
August 18, 2021

Morning Bell 17 August

Jessica Amir
August 17, 2021